PhaseV provides AI-driven solutions for efficient clinical development and operations.
PhaseV has raised $50.0M in total funding. The most recent round was Series A. The last funding was announced in May 2025.
PhaseV's investors include Accel, Insight Partners, Viola Ventures, LionBird, Exor Ventures.
PhaseV is headquartered in Boston, United States.
PhaseV provides AI-driven solutions for efficient clinical development and operations.
PhaseV is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PhaseV — Funding & Investors." VCBacked, May 13, 2025, https://www.vcbacked.co/company/phasev. Accessed July 19, 2026.
VCBacked. (2025). PhaseV — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/phasev
{{cite web |title=PhaseV — Funding & Investors |url=https://www.vcbacked.co/company/phasev |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated